Overview

Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis

Status:
Unknown status

Trial end date:
2020-10-01

Target enrollment:

Participant gender:

Summary

The overall purpose of this trial is to assess efficacy and safety of the combination of low doses of Methotrexate (MTX) with anti Tumor Necrosis Factor (TNF) alpha to improve initial efficacy and maintenance rate of anti-TNF alpha treatment in patients with psoriasis.

Phase:

Phase 4

Details

Lead Sponsor:

Assistance Publique Hopitaux De Marseille

Treatments:

Methotrexate